Key points are not available for this paper at this time.
In Brief BACKGROUND: The i-gel is a new single-use supraglottic airway device with a noninflatable cuff and an esophageal vent. METHOD: In this prospective, observational study, we evaluated the i-gel in 71 women. RESULTS: Insertion success rate was 97%. Insertion was easy and performed at the first attempt in every patient. Mean seal pressure was 30 ± 7 cm H2O, and average peak pressure was 11 ± 3 cm H2O. The gastric tube was inserted in 100% of cases. Only one case of coughing and one mild sore throat occurred. CONCLUSION: The i-gel is a reliable, easily inserted airway device that provides an adequate seal with a low morbidity rate. IMPLICATIONS: The i-gel is a new single-use supraglottic airway device with a noninflatable cuff and an esophageal vent. This first clinical study demonstrates a first insertion success rate of 97%, a mean leak pressure 30 ± 7 cm H2O, average peak pressure 11 ± 3 cm H2O, and a low morbidity rate.
Richez et al. (Tue,) studied this question.